Safety and effectiveness of the first balloon-in-basket pulsed field ablation system for the treatment of atrial fibrillation: VOLT CE Mark Study 6-month results
Jazyk angličtina Země Velká Británie, Anglie Médium print
Typ dokumentu klinické zkoušky, časopisecké články, multicentrická studie
Grantová podpora
Abbott
Investigator Grant Fellowships
National Health and Medical Research Council of Australia
PubMed
40163671
PubMed Central
PMC12036658
DOI
10.1093/europace/euaf072
PII: 8099431
Knihovny.cz E-zdroje
- Klíčová slova
- Atrial fibrillation, Balloon, Balloon-in-basket, Basket, Catheter ablation, Pulmonary vein isolation, Pulsed field ablation, Single-shot,
- MeSH
- časové faktory MeSH
- fibrilace síní * chirurgie patofyziologie diagnóza MeSH
- katetrizační ablace * přístrojové vybavení škodlivé účinky metody MeSH
- lidé středního věku MeSH
- lidé MeSH
- prospektivní studie MeSH
- recidiva MeSH
- senioři MeSH
- venae pulmonales * chirurgie patofyziologie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- klinické zkoušky MeSH
- multicentrická studie MeSH
AIMS: Pulsed field ablation (PFA) is a growing ablation modality for pulmonary vein isolation (PVI) in atrial fibrillation (AF) patients. This study assesses the 6-month safety and effectiveness of a novel balloon-in-basket, mapping-integrated PFA system, with a purpose-built form factor for PVI. METHODS AND RESULTS: The VOLT CE Mark Study is a prospective, multi-center, pre-market study. A total of 150 patients with drug-refractory paroxysmal (PAF) or persistent AF (PersAF) were enrolled between 8 November 2023 and 14 March 2024, of which 146 patients (age 64.1 ± 10.0 years, 63.0% male, 70.5% PAF) underwent PVI with the balloon-in-basket PFA catheter and system featuring integrated electroanatomic mapping with contact-sensing. Study endpoints were the rate of primary serious adverse events within 7 days as well as acute procedural effectiveness and 6-month freedom from recurrence. Acute effectiveness was achieved in 99.1% (573/578) of treated PVs (98.6% of patients, 144/146) with 17.6 ± 5.7 PFA applications/patient. Procedure, fluoroscopy, LA dwell, and transpired ablation times were 100.4 ± 33.0, 17.3 ± 12.1, 39.4 ± 20.6, and 31.4 ± 16.8 min, respectively. There were 4 (2.7%; 4/146) primary serious adverse events. The rate of freedom from documented atrial arrhythmias was 88.2% in PAF patients and 76.7% in PersAF patients (freedom from symptomatic recurrence was documented in 90.2% of PAF patients and 74.4% of PersAF patients) through 6-months post-index procedure. CONCLUSION: The VOLT CE Mark Study primary results demonstrate the safety and effectiveness of the novel balloon-in-basket PFA system to perform PVI in PAF and PersAF.
Cardiology Department Nemocnice Na Homolce Roentgenova 37 150 00 Praha 5 Czechia
Department of Cardiology and Intensive Care Medicine Asklepios Hospital St Georg Hamburg Germany
Department of Cardiology AZ Sint Jan Ruddershove 10 8000 Brugge Belgium
Department of Cardiology The Prince Charles Hospital 627 Rode Rd Chermside QLD 4032 Australia
Department of Cardiology UMC Utrecht Heidelberglaan 100 Utrecht 3584 CX Netherlands
Electrophysiology Abbott Minneapolis MN USA
German Center for Cardiovascular Research Partner Site Hamburg Kiel Lübeck Lübeck Germany
Heart Rhythm Management Center UZ Brussels Vrij Universiteit Brussel Brussels Belgium
Mount Sinai Fuster Heart Hospital One Gustave L Levy Medical Place New York New York 10029 USA
Zobrazit více v PubMed
Tzeis S, Gerstenfeld EP, Kalman J, Saad EB, Sepehri Shamloo A, Andrade JG et al. 2024 European heart rhythm association/heart rhythm society/Asia Pacific heart rhythm society/Latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace 2024;26:1–107.
Chun K-RJ, Schmidt B, Metzner A, Tilz R, Zerm T, Köster I et al. The ‘single big cryoballoon’ technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J 2008;30:699–709. PubMed PMC
Leitz P, Mönnig G, Güner F, Dechering DG, Wasmer K, Reinke F et al. Comparing learning curves of two established “single-shot” devices for ablation of atrial fibrillation. J Interv Card Electrophysiol 2018;53:317–22. PubMed
Heeger CH, Sohns C, Pott A, Metzner A, Inaba O, Straube F et al. Phrenic nerve injury during cryoballoon-based pulmonary vein isolation: results of the worldwide YETI registry. Circ Arrhythm Electrophysiol 2022;15:e010516. PubMed PMC
Tilz RR, Schmidt V, Pürerfellner H, Maury P, Chun K, Martinek M et al. A worldwide survey on incidence, management, and prognosis of oesophageal fistula formation following atrial fibrillation catheter ablation: the POTTER-AF study. Eur Heart J 2023;44:2458–69. PubMed PMC
Chun K-RJ, Miklavcic D, Vlachos K, Bordignon S, Scherr D, Jais P et al. State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective. Europace 2024;26:1–14. PubMed PMC
Ekanem E, Neuzil P, Reichlin T, Kautzner J, van der Voort P, Jais P et al. Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17 K study. Nat Med 2024;30:2020–9. PubMed PMC
Schmidt B, Bordignon S, Neven K, Reichlin T, Blaauw Y, Hansen J et al. EUropean real-world outcomes with pulsed field ablatiOn in patients with symptomatic atRIAl fibrillation: lessons from the multi-centre EU-PORIA registry. Europace 2023;25:1–11. PubMed PMC
Boersma L, Andrade JG, Betts T, Duytschaever M, Pürerfellner H, Santoro F et al. Progress in atrial fibrillation ablation during 25 years of europace journal. Europace 2023;25:1–14. PubMed PMC
Scherr D, Turagam MK, Maury P, Blaauw Y, van der Voort P, Neuzil P et al. Repeat procedures after pulsed field ablation for atrial fibrillation: MANIFEST-REDO study. Europace 2025:euaf012. PubMed
Sanders P, Healy S, Emami M, Kotschet E, Miller A, Kalman JM. Initial clinical experience with the balloon-in-basket pulsed field ablation system: acute results of the VOLT CE mark feasibility study. Europace 2024;26:1–10. PubMed PMC
Popa MA, Venier S, Menè R, Della Rocca DG, Sacher F, Derval N et al. Characterization and clinical significance of hemolysis after pulsed field ablation for atrial fibrillation: results of a multicenter analysis. Circ Arrhythm Electrophysiol 2024;17:e012732. PubMed
Mercado Montoya M, Gomez Bustamante T, Jessen M, Kulstad E, Mickelsen S, Overzet L. Quantification of hemolysis rates from pulsed field ablation. Eur Heart J 2024;45:ehae666.387.
Garg J, Chaudhary R, Palaniswamy C, Shah N, Krishnamoorthy P, Bozorgnia B et al. Cryoballoon versus radiofrequency ablation for atrial fibrillation: a meta-analysis of 16 clinical trials. J Atr Fibrillation 2016;9:1429. PubMed PMC
Van Belle Y, Janse P, Rivero-Ayerza MJ, Thornton AS, Jessurun ER, Theuns D et al. Pulmonary vein isolation using an occluding cryoballoon for circumferential ablation: feasibility, complications, and short-term outcome. Eur Heart J 2007;28:2231–7. PubMed
Reddy VY, Gerstenfeld EP, Natale A, Whang W, Cuoco FA, Patel C et al. Pulsed field or conventional thermal ablation for paroxysmal atrial fibrillation. N Engl J Med 2023;389:1660–71. PubMed
Vetta G, Della Rocca DG, Parlavecchio A, Magnocavallo M, Sorgente A, Pannone L et al. Multielectrode catheter-based pulsed electric field vs. Cryoballoon for atrial fibrillation ablation: a systematic review and meta-analysis. Europace 2024;26:1–12. PubMed PMC
Reddy VY, Calkins H, Mansour M, Wazni O, Di Biase L, Bahu M et al. Pulsed field ablation to treat paroxysmal atrial fibrillation: safety and effectiveness in the AdmIRE pivotal trial. Circulation 2024;150:1174–86. PubMed PMC
Saleemi S, Dashwood A, Kader Z, Bi A, Ky V, Young J et al. Pulsed field ablation (PFA) for atrial fibrillation: an analysis of immediate procedural outcomes and early discharge in 210 patients—insights from a single centre experience. Heart Lung Circ 2024;33:S442.
Verma A, Haines DE, Boersma LV, Sood N, Natale A, Marchlinski FE et al. Pulsed field ablation for the treatment of atrial fibrillation: PULSED AF pivotal trial. Circulation 2023;147:1422–32. PubMed PMC
Reddy VY, Peichl P, Anter E, Rackauskas G, Petru J, Funasako M et al. A focal ablation catheter toggling between radiofrequency and pulsed field energy to treat atrial fibrillation. JACC Clin Electrophysiol 2023;9:1786–801. PubMed
Turagam MK, Neuzil P, Schmidt B, Reichlin T, Neven K, Metzner A et al. Safety and effectiveness of pulsed field ablation to treat atrial fibrillation: one-year outcomes from the MANIFEST-PF registry. Circulation 2023;148:35–46. PubMed
Ruwald MH, Haugdal M, Worck R, Johannessen A, Hansen ML, Sørensen SK et al. Characterization of durability and reconnection patterns at time of repeat ablation after single-shot pulsed field pulmonary vein isolation. J Interv Card Electrophysiol 2024;67:379–87. PubMed PMC